C5AR2 in not only a prognostic biomarker, but also may play a key role in controlling tumor immune microenvironment in gliomas.
C5AR2 in not only a prognostic biomarker, but also may play a key role in controlling tumor immune microenvironment in gliomas. These findings suggest that C5AR2 is a potential prognostic marker and immunotherapeutic target in glioma.